Worldofdtcmarketing.com

Insight: Cancer drugs proving worth earlier in testing | Reuters Insight: Cancer drugs proving worth earlier in testing Related News FDA approves Roche drug for late-stage breast cancer Fri, Feb 22 2013 CORRECTED-UPDATE 3-FDA approves Roche drug...

by Gina Kolata:  She was a 32-year-old aerobics instructor from a Dallas suburb — healthy, college educated, with two young children. Nothing out of the ordinary, except one thing.   Her cholesterol was astoundingly low. Her low-density...

Accelerating the commercialization of promising new cancer treatments relies on ensuring that patients — individually and collectively — are actively involved throughout research and drug development. This was the consensus of leading scientists, advocates...

FRIDAY, July 12 (HealthDay News) — A new drug to treat advanced lung cancer has been approved by the U.S. Food and Drug Administration. Gilotrif (afatinib) is approved to treat patients with a specific subtype of of non-small cell lung cancer...

By Dr. Mercola According to the National Cancer Institute, in 2012 there were 14 million new cases of cancer diagnosed and 8.2 million cancer deaths worldwide.1 They anticipate the number of newly diagnosed cases will rise to over 20 million each year...